deltatrials
Unknown PHASE3 INTERVENTIONAL NCT00154440

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Treatment of Low-Grade Gastric Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type Stages IE & II1E (HELYX-Study)

Sponsor: Technische Universität Dresden

Conditions Lymphoma Lymphoma, Non-Hodgkin
Interventions amoxicillin clarithromycin metronidazole proton pump inhibitor radiation therapy
Updated 6 times since 2017 Last updated: Mar 23, 2007 Started: Nov 30, 2001 Completion: Oct 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Lymphoma and Lymphoma, Non-Hodgkin and is currently ongoing. Technische Universität Dresden leads this study, which shows 6 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotUnknown Status~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 21 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Sep 2020 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Jun 2018 — Sep 2020 [monthly]

    Unknown Status PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Nov 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Technische Universität Dresden
Data source: Technische Universität Dresden

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations